Opsumit

Ended Awarded Last action

Contract number
36C26124N0731
Awardee
Awarding agency
Obligated
$21,613

Award facts

Contract value 100% obligated
$21,612.51 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Titusville, Hopewell Township, NJ 08560, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$7,204
Original award $28,817

About this award

This is a $21,612.51 firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer. The contract is for the drug Opsumit, which is used to treat pulmonary arterial hypertension, a rare and serious condition that primarily affects veterans and other federal beneficiaries.

The contract is issued against Actelion's $219,108,390 Federal Supply Schedule (FSS) contract with the VA for Pharmaceuticals and Drugs (FSS-61-IB), which runs from August 2024 to July 2029. Actelion also holds two Blanket Purchase Agreements (BPAs) with the VA National Acquisition Center, worth $118.5 million and $83.5 million respectively, to facilitate streamlined access to Actelion's pulmonary arterial hypertension therapies for VA medical centers and other federal healthcare providers. This delivery order contract does not utilize any small business set-asides.

Quick answers

Who was awarded contract 36C26124N0731?

36C26124N0731 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on June 21, 2024.

How much is contract 36C26124N0731 worth?

The government has obligated $21,613 on 36C26124N0731.

Is contract 36C26124N0731 an order under another contract?

Yes. 36C26124N0731 is a delivery order under 36F79719D0142, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26124N0731 competed?

The extent of competition for 36C26124N0731 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award